FDA Approves Kalydeco for Cystic Fibrosis Patients with R117H Mutation
Cystic Fibrosis, News
The U.S. Food and Drug Administration (FDA) has approved the prescription of Kalydeco (ivacaftor) for the treatment of cystic fibrosis (CF) patients 6 years and older with the R117H mutation in the ... Read more